• 1
    Pallansch M.A., Roos R.P. (2007) Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In: Knipe D.M., Howley P.M., eds. Fields Virology, fifth edn. Philadelphia: Lippincott Williams & Wilkins, pp. 83993.
  • 2
    Bible J.M., Pantelidis P., Chan P.K.S., Tong C.Y.W. (2007) Genetic evolution of enterovirus 71: epidemiological and pathological implications. Rev Med Virol 17: 3719.
  • 3
    Brown B.A., Oberste M.S., Alexander J.P., Jr, Kennett M.L., Pallansch M.A. (1999) Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol 73: 996975.
  • 4
    Mizuta K., Abiko C., Murata T., Matsuzaki Y., Itagaki T., Sanjoh K., Sakamoto M., Hongo S., Murayama S., Hayasaka K. (2005) Frequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003. J Clin Microbiol 43: 61715.
  • 5
    Tu P.V., Thao N.T.T., Perera D., Huu T.K., Tien T.N.K., Thuong T.C., How O.M., Cardosa M.J., McMinn P.C. (2007) Epidemiologic and virologic investigation of hand, foot, and mouth disease, Southern Vietnam, 2005. Emerg Infect Dis 13: 173341.
  • 6
    van der Sanden S., Koopmans M., Uslu G., van der Avoort H., on behalf of the Dutch Working Group for Clinical Virology. (2009) Epidemiology of enterovirus 71 in The Netherlands, 1963 to 2008. J Clin Microbiol 47: 282633.
  • 7
    Wu C., Lin Y., Fann C., Liao N., Shih S., Ho M. (2002) Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 20: 895904.
  • 8
    Chen H., Chang M., Chiang B., Jeng S. (2006) Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71. Vaccine 24: 294451.
  • 9
    Lee M.S., Chang L.Y. (2010) Development of enterovirus 71 vaccines. Expert Rev Vaccines 9: 1495.
  • 10
    Li L., He Y., Yang H., Zhu J., Xu X., Dong J., Zhu Y., Jin Q. (2005) Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China. J Clin Microbiol 43: 38359.
  • 11
    Perera D., Yusof M.A., Podin Y., Ooi M.H., Thao N.T.T., Wong K.K., Zaki A., Chua K.B., Malik Y.A., Tu P.V., Tien N.T.K., Puthavathana P., McMinn P.C., Cardosa M.J. (2007) Molecular phylogeny of modern coxsackievirus A16. Arch Virol 152: 12018.
  • 12
    Hosoya M., Kawasaki Y., Sato M., Honzumi K., Hayashi A., Hiroshima T., Ishiko H., Kato K., Suzuki H. (2007) Genetic diversity of coxsackievirus A16 associated with hand, foot and mouth disease epidemics in Japan from 1983 to 2003. J Clin Microbiol 45: 11220.
  • 13
    Iwai M., Masaki A., Hasegawa S., Obara M., Horimoto E., Nakamura K., Tanaka Y., Endo K., Tanaka K., Ueda J., Shiraki K., Kurata T., Takizawa T. (2009) Genetic changes of coxsackievirus A16 and enterovirus 71 isolated from hand, foot and mouth disease patients in Toyama, Japan between 1981 and 2007. Jpn J Infect Dis 62: 2549.
  • 14
    Zhang Y., Wang D., Yan D., Zhu S., Liu J., Wang H., Zhao S., Yu D., Nan L., An J., Chen L., An H., Xu A., Xu W. (2010) Molecular evidence of persistent epidemic and evolution of subgenotype B1 coxsackievirus A16-associated hand, foot, and mouth disease in China. J Clin Microbiol 48: 61922.
  • 15
    Li Y., Zhu R., Qian Y., Deng J., Sun Y., Liu L., Wang F., Zhao L. (2011) Comparing enterovirus 71 with coxsackievirus A16 by analyzing nucleotide sequences and antigenicity of recombinant proteins of VP1s and VP4s. BMC Microbiol 11: 246.
  • 16
    Legay F., Lévêque N., Gacouin A., Tattevin P., Bouet J., Thomas R., Chomel J. (2007) Fatal coxsackievirus A-16 pneumonitis in adults. Emerg Infect Dis 13: 10846.
  • 17
    Goto M., Sanefuji M., Kusuhara K., Nishimura Y., Shimizu H., Kira R. Torisu H., Hara T. (2009) Rhombencephalitis and coxsackievirus A16. Emerg Infect Dis 15: 168991.
  • 18
    Wang C., Lu F.L., Wu M., Lee C., Huang L. (2004) Fatal coxsackievirus A16 infection. Pediatr Infect Dis J 23: 2756.
  • 19
    Mao Q., Wang Y., Gao R., Shao J., Yao X., Lang S., Wang C., Mao P., Liang Z., Wang J. (2012) A neonatal mouse model of coxsackievirus A16 for vaccine evaluation. J Virol 86: 11,96776.
  • 20
    Liu Q., Yan K., Feng Y., Huang X., Ku Z., Cai Y., Liu F., Shi J., Huang Z. (2012) A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge. Vaccine 30: 66428.
  • 21
    Xu W., Liu C., Yan L., Li J., Wang L., Qi Y., Cheng R., Xiong X. (2012) Distribution of enteroviruses in hospitalized children with hand, foot, and mouth disease and relationship between pathogens and nervous system complications. Virology J 9: 8.
  • 22
    Oberste M.S., Maher K., Kilpatrick D.R., Pallansch M.A. (1999) Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol 73: 19418.
  • 23
    Mizuta K., Aoki Y., Suto A., Ootani K., Katsushima N., Itagaki T. Ohmi A., Okamoto M., Nishimura H., Matsuzaki Y., Hongo S., Sugawara K., Shimizu H., Ahiko T. (2009) Cross-antigenicity among EV71 strains from different genogroups isolated in Yamagata, Japan, between 1990 and 2007. Vaccine 27: 31538.
  • 24
    Mizuta K., Abiko C., Aoki Y., Suto A., Hoshina H., Itagaki T., Katsushima N., Matsuzaki Y., Hongo S., Noda M., Kimura H., Ootani K. (2008) Analysis of monthly isolation of respiratory viruses from children by cell culture using a microplate method: a two-year study from 2004 to 2005 in Yamagata, Japan. Jpn J Infect Dis 61: 196201.
  • 25
    Oberste M.S., Maher K., Flemister M.R., Marchetti G., Kilpatrick D.R., Pallansch M.A. (2000) Comparison of classic and molecular approaches for the identification of untypeable enteroviruses. J Clin Microbiol 38: 11704.
  • 26
    Saitou N., Nei M. (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4: 40625.